However, the incremental trials required before a commercial vaccine could be rolled out are still a lengthy undertaking – and an essential one to ensure that even rare side-effects are spotted. A commercially available vaccine within a year would be quick.
Not really and not quite. There’s a rather large amount of bureaucratic form filling that is required. We can argue about how much is sensible with standard treatments. In fact, we do, I coming down on the side of the FDA etc being hopelessly, counter-productively, strict and expensive on such matters. More die because of the delays than are saved by the absence of side effects that is.
And sure, there are fast lanes for vaccines for something threatening to go pandemic and all that. But it’s still true that significant parts of the delay are imposed by the regulatory process, not the development one. And, you know, perhaps we should lift some chunk of that regulatory delay?